Skip to content

Ephedrine

Akovaz, Corphedra, Emerphed, Ephedrine Sulfate (ephedrine) is a small molecule pharmaceutical. Ephedrine was first approved as Akovaz on 2016-04-29. It is used to treat asthma, bronchial spasm, orthostatic hypotension, and rhinitis in the USA. The pharmaceutical is active against beta-2 adrenergic receptor. Primatene's patents are valid until 2040-05-16 (FDA).
Trade Name Akovaz, Corphedra, Emerphed, Ephedrine Sulfate
Common Name Ephedrine
Indication asthma, bronchial spasm, orthostatic hypotension, rhinitis
Drug Class Sympathomimetics
Ephedrine
Get full access now